BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld
Home
» EASL Safety Data Drop Anadys Shares; Schering and Salix Rise
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
EASL Safety Data Drop Anadys Shares; Schering and Salix Rise
April 24, 2009
By
Trista Morrison
No Comments
As the 44th annual meeting of the European Association for the Study of the Liver (EASL) swung into high gear Thursday, data from Anadys Pharmaceuticals Inc., Schering-Plough Corp. and Salix Pharmaceuticals Ltd. garnered headlines. (BioWorld Today)
BioWorld